Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $70.15 USD
Change Today +1.20 / 1.74%
Volume 1.2K
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - astrazeneca plc (AZNCF)

Name (Connections)Board RelationshipsTitleKey Developments
Jean-Philippe Courtois 70 RelationshipsNon-Executive Director and Member of Audit CommitteeAstrazeneca Announces Revised Results for the Year 2003 and First Half of 2004
10/25/04
Donald Burlington M.D. 30 RelationshipsNon-Executive Director, Member of Audit Committee and Member of Science CommitteeAstraZeneca's Marketing Of Drugs Is Investigated
03/11/03
Ann Cairns MSc 11 RelationshipsNon-Executive Director and Member of Audit Committee 

Compensation Committee* - astrazeneca plc (AZNCF)

Name (Connections)Board RelationshipsTitle
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance Committee
Leif Johansson MSc Eng. 93 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration Committee
AZNCF Compensation vs. Industry
1.1M
441.9K
Chief Executive Officer
680.0K
293.1K
Chief Financial Officer
Share price activity for ASTRAZENECA PLC (AZNCF)
52 Week Price Performance
AZNCF
Industry Average

Nominating Committee* - astrazeneca plc (AZNCF)

Name (Connections)Board RelationshipsTitleKey Developments
Leif Johansson MSc Eng. 93 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration CommitteeAstraZeneca PLC Elects Cori Bargmann as Director
04/24/15
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance CommitteeAstraZeneca PLC Proposes Board Changes
02/17/15

Corporate Governance Committee* - astrazeneca plc (AZNCF)

Name (Connections)Board RelationshipsTitle
Graham Chipchase 18 RelationshipsNon-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance Committee
Leif Johansson MSc Eng. 93 RelationshipsNon-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration Committee
AZNCF and Competitor
Insiders vs. External
Board
17%
83%
AstraZeneca PLC
9%
91%
Biogen Inc.
11%
89%
Celgene Corporation
13%
87%
Eli Lilly and Company
11%
89%
Valeant Pharmaceuticals International, Inc.
7%
93%
BASF SE
Insiders
External Board Members
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AZNCF:US $70.15 USD +1.20

AZNCF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BASF SE €87.94 EUR +0.181
Biogen Inc $398.68 USD -2.47
Celgene Corp $116.09 USD -0.11
Eli Lilly & Co $74.30 USD +0.03
Valeant Pharmaceuticals International Inc C$291.64 CAD +6.41
View Industry Companies
 

Industry Analysis

AZNCF

Industry Average

Valuation AZNCF Industry Range
Price/Earnings 68.5x
Price/Sales 3.4x
Price/Book 5.2x
Price/Cash Flow 68.5x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.